Detroit

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple myeloma

Running trials

• Active, not recruiting

  A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

  NCT03989414· Phase 1/2· Celgene· Source